A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
Abroad (travel likely)RecruitingPHASE2, PHASE3
Conditions
Metastatic Colorectal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Center for Cancer Prevention and Treatment of Sun Yat-sen University, Guangzhou, Guangdong, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Linyi Cancer Hospital, Linyi, China
Fudan University Affiliated Oncology Hospital, Shanghai, China
National Cancer Center, Kashiwa, Japan
Study leads
Ruihua Xu
Study Chair
Center for Cancer Prevention and Treatment of Sun Yat-sen University